Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

Patients with metastatic renal cell cancer (mRCC) who respond to upfront immune checkpoint inhibitor (ICI) combination therapies may be treated with cytoreductive nephrectomy (CN) to remove radiographically viable primary tumors. Early data for post-ICI CN suggested that ICI therapies induce desmopl...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2023-04-01
Serie:	European Urology Open Science
Soggetti:	Cytoreductive nephrectomy Immune checkpoint inhibitor Renal cell carcinoma Complications
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2666168323001052
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!